The mutational landscape of a prion-like domain
- PMID: 31519910
- PMCID: PMC6744496
- DOI: 10.1038/s41467-019-12101-z
The mutational landscape of a prion-like domain
Abstract
Insoluble protein aggregates are the hallmarks of many neurodegenerative diseases. For example, aggregates of TDP-43 occur in nearly all cases of amyotrophic lateral sclerosis (ALS). However, whether aggregates cause cellular toxicity is still not clear, even in simpler cellular systems. We reasoned that deep mutagenesis might be a powerful approach to disentangle the relationship between aggregation and toxicity. We generated >50,000 mutations in the prion-like domain (PRD) of TDP-43 and quantified their toxicity in yeast cells. Surprisingly, mutations that increase hydrophobicity and aggregation strongly decrease toxicity. In contrast, toxic variants promote the formation of dynamic liquid-like condensates. Mutations have their strongest effects in a hotspot that genetic interactions reveal to be structured in vivo, illustrating how mutagenesis can probe the in vivo structures of unstructured proteins. Our results show that aggregation of TDP-43 is not harmful but protects cells, most likely by titrating the protein away from a toxic liquid-like phase.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Gain-of-function profilin 1 mutations linked to familial amyotrophic lateral sclerosis cause seed-dependent intracellular TDP-43 aggregation.Hum Mol Genet. 2016 Apr 1;25(7):1420-33. doi: 10.1093/hmg/ddw024. Epub 2016 Jan 28. Hum Mol Genet. 2016. PMID: 26908597
-
ALS-Causing Mutations Significantly Perturb the Self-Assembly and Interaction with Nucleic Acid of the Intrinsically Disordered Prion-Like Domain of TDP-43.PLoS Biol. 2016 Jan 6;14(1):e1002338. doi: 10.1371/journal.pbio.1002338. eCollection 2016 Jan. PLoS Biol. 2016. PMID: 26735904 Free PMC article.
-
Review: Prion-like mechanisms of transactive response DNA binding protein of 43 kDa (TDP-43) in amyotrophic lateral sclerosis (ALS).Neuropathol Appl Neurobiol. 2015 Aug;41(5):578-97. doi: 10.1111/nan.12206. Epub 2015 Apr 20. Neuropathol Appl Neurobiol. 2015. PMID: 25487060 Review.
-
The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?Brain. 2019 May 1;142(5):1176-1194. doi: 10.1093/brain/awz078. Brain. 2019. PMID: 30938443 Free PMC article. Review.
-
Protein aggregates and regional disease spread in ALS is reminiscent of prion-like pathogenesis.Neurol India. 2013 Mar-Apr;61(2):107-10. doi: 10.4103/0028-3886.111109. Neurol India. 2013. PMID: 23644307 Review.
Cited by
-
RNA-binding and prion domains: the Yin and Yang of phase separation.Nucleic Acids Res. 2020 Sep 25;48(17):9491-9504. doi: 10.1093/nar/gkaa681. Nucleic Acids Res. 2020. PMID: 32857852 Free PMC article.
-
A Zn-dependent structural transition of SOD1 modulates its ability to undergo phase separation.EMBO J. 2023 Jan 16;42(2):e111185. doi: 10.15252/embj.2022111185. Epub 2022 Nov 23. EMBO J. 2023. PMID: 36416085 Free PMC article.
-
Scanning mutagenesis of the voltage-gated sodium channel NaV1.2 using base editing.Cell Rep. 2023 Jun 27;42(6):112563. doi: 10.1016/j.celrep.2023.112563. Epub 2023 Jun 1. Cell Rep. 2023. PMID: 37267104 Free PMC article.
-
Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer's disease.Brain. 2020 Dec 1;143(12):3842-3849. doi: 10.1093/brain/awaa315. Brain. 2020. PMID: 33188391 Free PMC article.
-
The genetic landscape for amyloid beta fibril nucleation accurately discriminates familial Alzheimer's disease mutations.Elife. 2021 Feb 1;10:e63364. doi: 10.7554/eLife.63364. Elife. 2021. PMID: 33522485 Free PMC article.
References
-
- Buratti, E. Functional Significance of TDP-43 Mutations in Disease. Adv. Genet. 91, 1–53 (2015). - PubMed
-
- Chiti F, Stefani M, Taddei N, Ramponi G, Dobson CM. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature. 2003;424:805–808. - PubMed
-
- Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 2006;75:333–366. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous
